What questions should I ask my oncologist about HER2-Positive Breast Cancer

Key Questions to Ask Your Oncologist About HER2-Positive Breast Cancer

Since you have HER2-positive breast cancer, here are important questions organized by topic to help you understand your diagnosis and treatment options:

About Your Specific HER2 Status

1. What is my exact HER2 level or expression?

   • According to research on HER2 protein measurement, HER2 levels can vary significantly. Understanding whether you have high HER2 expression (typically above 750 amol per microgram) versus lower levels matters because it affects which treatments may work best for you.

2. How was my HER2 status determined? (IHC score, FISH test, or other methods?)

   • Different testing methods can show different results. Ask if your doctor used immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), or newer proteomics testing.

3. Are there other biomarkers I should know about? (hormone receptor status, tumor mutational burden, etc.)

   • Your cancer may have additional characteristics beyond HER2 that influence treatment decisions.

About Treatment Options

1. What anti-HER2 therapies are you recommending, and why?

   • Common options include trastuzumab (Herceptin), pertuzumab (Perjeta), and trastuzumab deruxtecan (Enhertu). Ask your doctor which combination they recommend for your specific situation.

2. Will I receive dual anti-HER2 therapy (two different HER2-targeting drugs together)?

   • Research shows that combining two anti-HER2 drugs (like pertuzumab and trastuzumab) can improve outcomes compared to single-agent therapy, especially for patients with high HER2 expression.

3. What chemotherapy will be combined with my HER2-targeted therapy?

   • Most HER2-positive breast cancer treatment involves chemotherapy plus anti-HER2 drugs working together. Understanding the specific chemotherapy regimen (like TCHP: docetaxel, carboplatin, trastuzumab, and pertuzumab) helps you prepare for side effects.

4. Am I a candidate for newer antibody-drug conjugates like Enhertu?

   • Enhertu (trastuzumab deruxtecan) is an FDA-approved option that combines an anti-HER2 antibody with a chemotherapy drug. Ask if this is appropriate for your case, especially if you have lower HER2 expression.

About Side Effects & Monitoring

1. What side effects should I expect, and how will they be managed?

   • Common side effects include fatigue, nausea, hair loss, and neuropathy (numbness/tingling). Ask specifically about:
     • Heart function monitoring (since anti-HER2 drugs can affect the heart)
     • Blood count monitoring
     • Skin reactions (if applicable)

2. How will my heart function be monitored during treatment?

   • Anti-HER2 drugs like trastuzumab require regular heart monitoring with tests like MUGA scans or echocardiograms. Ask about the schedule and what to watch for.

3. What blood tests will I need, and how often?

   • Weekly blood work is common during chemotherapy to monitor infection risk and blood cell counts.

About Your Treatment Plan

1. What is the goal of my treatment? (cure, remission, disease control?)

   • Understanding whether treatment aims for cure or long-term control helps set realistic expectations.

2. How long will treatment last?

   • Ask about the total duration of chemotherapy, anti-HER2 therapy, and any maintenance therapy afterward.

3. What happens after my initial treatment ends?

   • Many HER2-positive patients continue anti-HER2 therapy for extended periods. Ask about maintenance treatment plans.

4. How will we know if the treatment is working?

   • Ask about imaging schedules (CT scans, PET scans) and other markers your doctor will use to assess response.

About Clinical Trials

1. Are there clinical trials I should consider?

   • Ask if you're eligible for trials testing newer combinations or approaches, especially if you have specific biomarker characteristics.

2. What clinical trials are available for HER2-positive breast cancer at your institution or nearby?

About Your Overall Care

1. What support services are available? (nutrition, mental health, survivorship programs)

   • Cancer treatment affects your whole life. Ask about counseling, support groups, and other resources.

2. Who should I contact if I have side effects or concerns between appointments?

   • Know how to reach your care team urgently if needed.

3. Will I need radiation or surgery, and when?

   • Ask about the sequencing of different treatments and what to expect.

---

Why These Questions Matter

According to clinical guidance on HER2-positive breast cancer, your specific HER2 expression level, combined with other tumor characteristics, helps your oncologist choose between different anti-HER2 drugs and combinations. Patients with very high HER2 expression may have different treatment options than those with lower levels.

Understanding your treatment plan—including why specific drugs were chosen, what side effects to expect, and how success will be measured—helps you become an active partner in your care and prepares you mentally and physically for what's ahead.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.